Arm Swing During Walking in Early Multiple Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

28 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-12-01

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multiple sclerosis (MS) is the most common central nervous system inflammatory demyelinating disease which causes motor and sensory deficits, cerebellar symptoms, and balance problems. Due to these symptoms, gait abnormalities are common in MS, even in patients with low degrees of impairment. The upper limb has an important role on postural control and gait stability. Affected arm swing movement and asymmetry during gait are common in neurological disorders such as Parkinson's disease (PD) even in early stages of the disease and arm swing treatment has been acknowledged to enhance gait and normalize arm swing in individuals with PD.

The presence of arm swing changes during walking in MS patients, similar to PD, especially in the early period, may be an indicator of balance problems, this was, however, not investigated as such. Therefore, the aim of the current study is to assess the arm swing during gait in people with MS shortly after their diagnosis in early MS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

3 Meter Backwards Walk Test and Multiple Sclerosis

NCT04004026

Multiple Sclerosis Walking, Difficulty Balance; Distorted

COMPLETED

Dual-Task Performance in Patients With Multiple Sclerosis

NCT03508284

Multiple Sclerosis

COMPLETED

Relationship of Position Sense With Gait and Balance in Patients With Multiple Sclerosis

NCT04547400

Multiple Sclerosis

COMPLETED

Tele-Assessment and Face-to-Face Evaluation of Balance in MS

NCT04743284

Multiple Sclerosis

COMPLETED

Gait Analysis in Multiple Sclerosis Patients

NCT05299151

Multiple Sclerosis 3D Gait Analysis Vestibular Rehabilitation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis Upper Extremity Problem Gait Disorders, Neurologic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early Multiple Sclerosis

Arm swing evaluation and functional tests will be tested in this group.

Evaluation of the arm swing during gait

Intervention Type OTHER

Evaluation of the arm swing during gait: The difference between the maximum flexion and extension of the shoulder is the arm swing amplitude during walking. The arm swing amplitude will be evaluated 2-dimensionally with the help of the Kinovea video player.

Functional Tests

Intervention Type OTHER

To understand the changes in functional mobility, Two Minute Walk Test (2MWT), Timed Up and Go (TUG) and Timed 25Foot Walk Test (T25FW) were conducted.

Healthy Controls

Arm swing evaluation will be tested in this group.

Evaluation of the arm swing during gait

Intervention Type OTHER

Evaluation of the arm swing during gait: The difference between the maximum flexion and extension of the shoulder is the arm swing amplitude during walking. The arm swing amplitude will be evaluated 2-dimensionally with the help of the Kinovea video player.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evaluation of the arm swing during gait

Evaluation of the arm swing during gait: The difference between the maximum flexion and extension of the shoulder is the arm swing amplitude during walking. The arm swing amplitude will be evaluated 2-dimensionally with the help of the Kinovea video player.

Intervention Type OTHER

Functional Tests

To understand the changes in functional mobility, Two Minute Walk Test (2MWT), Timed Up and Go (TUG) and Timed 25Foot Walk Test (T25FW) were conducted.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Arm swing during walking Two Minute Walk Test (2MWT), Timed Up and Go (TUG) and Timed 25Foot Walk Test (T25FW)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who were diagnosed with MS in the last 30 days,
* Patients who were recovered from their symptoms and were clinically stable

Exclusion Criteria

* Patients who had an acute medical illness in the past 6 months, any other neurological and psychiatric diseases
* Patients who had any orthopedic, rheumatologic, or vestibular conditions that affect walking
* Patients who had exacerbations between the first and second evaluations

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes